Verition Fund Management LLC Immunity Bio, Inc. Transaction History
Verition Fund Management LLC
- $20.3 Billion
- Q2 2025
A detailed history of Verition Fund Management LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 245,801 shares of IBRX stock, worth $607,128. This represents 0.0% of its overall portfolio holdings.
Number of Shares
245,801
Previous 827,039
70.28%
Holding current value
$607,128
Previous $2.49 Million
73.97%
% of portfolio
0.0%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding IBRX
# of Institutions
274Shares Held
120MCall Options Held
2.47MPut Options Held
3.13M-
Vanguard Group Inc Valley Forge, PA21.8MShares$53.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$28.2 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC8.76MShares$21.6 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.76MShares$19.2 Million0.36% of portfolio
-
Jane Street Group, LLC New York, NY7.72MShares$19.1 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $989M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...